| Literature DB >> 33834449 |
Ji-Yoon Lee1, Sang Kyum Kim2, Kiho Lee3, Soo Jin Oh4,5.
Abstract
Drug metabolism and pharmacokinetics (DMPK) are fundamental in drug discovery. New chemical entities (NCEs) are typically evaluated with various in vitro and in vivo assays, which are time-consuming and labor intensive. These experiments are essential in identifying potential new drugs. Recently, mass spectrometry (MS) has played a key role in examining the drug-like properties of NCEs. Quantitative and qualitative mass spectrometry approaches are routinely utilized to obtain high-quality data in an efficient, timely, and cost-effective manner. Especially, liquid chromatography (LC) coupled with MS technology has been refined for metabolite identification (Met ID), which is critical for lead optimization. These qualitative and quantitative MS approaches and their specific utility in DMPK characterization will be described in this chapter.Entities:
Keywords: Drug discovery; Drug metabolism; Mass spectrometry; Pharmacokinetics
Mesh:
Substances:
Year: 2021 PMID: 33834449 DOI: 10.1007/978-981-33-6064-8_20
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622